MedTrace Logo

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX

NCT07505875 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-04-06

No results posted yet for this study

Summary

The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.

Conditions

  • Substance Use
  • HIV Prevention
  • Sexually Transmitted Infections (STIs)

Interventions

BEHAVIORAL

Understanding of chemsex patterns, impacts, and service needs among transgender persons

: During study period (single visit within \~12 months study duration)

Sponsors & Collaborators

  • amfAR, The Foundation for AIDS Research

    collaborator OTHER

  • Institute of HIV Research and Innovation Foundation, Thailand

    lead OTHER

Principal Investigators

  • Nittaya Phanuphak, MD,PhD. · Institute of HIV Research and Innovation (IHRI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2026-12-01
Completion
2027-05-01

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07505875 on ClinicalTrials.gov